GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Medi Caps Ltd-$

Medi Caps Q2 FY27 Standalone Profit Rs. 52.68 Lacs; Half-Year Loss Rs. -111.63 Lacs

RESULTS ▲ Positive Development HIGH RISK
📅 Filed on BSE: 04 Nov 2026, 04:58 PM IST  ·  BSE ID: 8cdb87a7-eef5-4c21-9019-fc0108250f14
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported a standalone net profit for the quarter, but a net loss for the first half of the financial year.
🤖 AI Summary
  • Medi Caps Ltd. reported unaudited standalone net profit of Rs. 52.68 Lacs for Q2 FY27.
  • Standalone net loss for the half-year ended September 30, 2026, was Rs. -111.63 Lacs.
  • Revenue from operations for the quarter ended September 30, 2026, was Rs. 12.27 Lacs.
  • Total expenses for the quarter ended September 30, 2026, amounted to Rs. 65.55 Lacs.
  • The Board approved unaudited standalone and consolidated financial results on November 4, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Standalone Net Profit (Q2 FY27)
52.68 Lacs
Not comparable — limited prior period data.
Standalone Net Loss (Half Year FY27)
-111.63 Lacs
Not comparable — limited prior period data.
Standalone Revenue from Operation (Q2 FY27)
12.27 Lacs
Not comparable — limited prior period data.
Standalone Total Expenses (Q2 FY27)
65.55 Lacs
Not comparable — limited prior period data.
Cash and Cash Equivalents (As at 30.09.2026)
2.14 Lacs
🏢 How This Affects the Company
📈
Business Impact
The operational revenue of Rs. 12.27 Lacs in Q2 FY27 indicates current business activity levels, while the half-year net loss suggests ongoing challenges in scaling operations for consistent profitability.
💰
Financial Impact
The Q2 FY27 standalone net profit of Rs. 52.68 Lacs contributes to mitigating the half-year net loss of Rs. -111.63 Lacs, reflecting variability in quarterly financial performance. Cash and cash equivalents increased from Rs. 0.70 Lacs at the beginning of the year to Rs. 2.14 Lacs as of September 30, 2026.
⚙️
Operational Impact
The expenses of Rs. 65.55 Lacs in Q2 FY27 for operations suggest ongoing commitments to employee benefits, depreciation, and other overheads relative to the revenue generated.
⚠️
Risk Impact
The half-year net loss of Rs. -111.63 Lacs indicates a continued financial risk, despite a profitable Q2. The variability between quarters may introduce uncertainty regarding sustained profitability.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, with the Q2 FY27 standalone net profit at Rs. 52.68 Lacs and half-year net loss at Rs. -111.63 Lacs.
🔍
Management Signal
The approval of unaudited financial results by the Board of Directors signals adherence to regulatory reporting requirements and transparency in financial disclosure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — observe sustained profitability trends.
Cash flow statement for H2 FY27 — evaluate liquidity management.
Any updates on operational scaling or business development initiatives.
HIGH RISK The company recorded a significant net loss for the half-year, indicating ongoing financial challenges.
💡 Investor Takeaway
Medi Caps Ltd. reported a standalone net profit of Rs. 52.68 Lacs for Q2 FY27, an improvement from Q1 FY27's net loss of Rs. -58.96 Lacs. However, the half-year ended September 30, 2026, still reflects a standalone net loss of Rs. -111.63 Lacs.
⚖️ Strengths & Concerns

✅ Positives

  • Medi Caps Ltd. achieved a standalone net profit of Rs. 52.68 Lacs for the quarter ended September 30, 2026.
  • Cash and cash equivalents increased from Rs. 0.70 Lacs at year beginning to Rs. 2.14 Lacs by September 30, 2026.

⚠️ Concerns

  • The standalone net loss for the half-year ended September 30, 2026, was Rs. -111.63 Lacs.
  • Revenue from operations for the half-year ended September 30, 2026, was Rs. 22.77 Lacs, reflecting limited operational scale.
📅 Company Track Record
Medi Caps Ltd. reported a standalone net loss of -58.96 Lacs in Q1 FY27 and a net profit of 52.68 Lacs in Q2 FY27. For the full year ended March 31, 2026, the company recorded a net loss of -13.87 Lacs. The company also appointed a new CFO and Whole Time Director on August 6, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Medi Caps Ltd.'s standalone net profit for Q2 FY27?
Medi Caps Ltd. reported an unaudited standalone net profit of Rs. 52.68 Lacs for the quarter ended September 30, 2026 (Q2 FY27).
What was Medi Caps Ltd.'s standalone net loss for the half-year ended September 30, 2026?
The standalone net loss for Medi Caps Ltd. for the half-year ended September 30, 2026, was Rs. -111.63 Lacs.
What was Medi Caps Ltd.'s revenue from operations for Q2 FY27?
Revenue from operations for Medi Caps Ltd. for the quarter ended September 30, 2026 (Q2 FY27) was Rs. 12.27 Lacs.
What were the total expenses for Medi Caps Ltd. in Q2 FY27?
Total expenses for Medi Caps Ltd. for the quarter ended September 30, 2026 (Q2 FY27) were Rs. 65.55 Lacs.
What was the cash and cash equivalents balance for Medi Caps Ltd. as of September 30, 2026?
As of September 30, 2026, Medi Caps Ltd.'s cash and cash equivalents stood at Rs. 2.14 Lacs.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.